Physician profile
Mark Yakavonis
NPI 1225395783
$12,167.69
in general payments reported to CMS, 2019-2025
12 companies · $1,567 in 2025
The $1,567 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,607 · 2021: $2,507 · 2022: $2,177 · 2023: $1,964 · 2024: $1,345 · 2025: $1,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,159 · Grant: $1,500 · Food and Beverage: $1,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,159.20 |
| Grant | $1,500.00 |
| Food and Beverage | $1,217.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,430.97 | 2019-2022 | |
| Medshape, INC. | $1,839.27 | 2023-2024 | Dynanail Helix, Washer, 15 Mm, Dynanail Mini, Dynanail |
| Arthrex, INC. | $1,719.62 | 2019-2022 | |
| Smith+Nephew, INC. | $1,630.28 | 2022-2025 | Stravix |
| Trilliant Surgical LLC. | $1,317.07 | 2023-2024 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Minimally Invasive Bunion Plate, Left |
| Biotissue Holdings INC. | $98.31 | 2023 | |
| Aroa Biosurgery Incorporated | $45.48 | 2025 | |
| Orthofix Medical, INC. | $23.60 | 2022 | |
| Ethicon US, LLC | $21.13 | 2025 | Vistaseal, Dermabond Prineo, Ethicon |
| Kairos Surgical INC | $15.67 | 2023 | |
| Paragon 28, INC. | $15.43 | 2019 | |
| Axogen | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Yakavonis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.